Science

exclusiveNation

(FILES) This file photo taken on April 29, 2020, shows an engineer working at the Quality Control Laboratory on an experimental vaccine for the COVID-19 coronavirus at the Sinovac Biotech facilities in Beijing. - Sinovac Biotech is conducting one of the five clinical trials of potential vaccines that have been authorised in China. China would make any coronavirus vaccine it developed a "global public good" once it was put into use, President Xi Jinping told the World Health Assembly on May 18, 2020. (Photo by NICOLAS ASFOURI / AFP)

Aussie volunteers step up for vaccine trial

Hopes rise that vaccine could be available within a year as Brisbane, Melbourne volunteers take part in Australia’s first human clinical trials.

Natasha Robinson

researchWorld

The Moderna headquarters are seen in Cambridge, Massachusetts on May 18, 2020. - US biotech firm Moderna reported promising early results from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of volunteers. The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people who received it similar to that seen in people convalescing from the virus. (Photo by Joseph Prezioso / AFP)

Share price rockets as vaccine hopes rise

A coronavirus vaccine being developed by US company Moderna has shown early promise and is an ‘important first step’, the company says.

Jacquelin Magnay

treatmentScience

19/05/20 Dr Stephen Muhi is an infectious disease specialist at the Royal Melbourne Hospital, pictured in the COVID-19 staff testing area. Aaron Francis/The Australian

Australians to test ‘Trump’s drug’

More than 2000 healthcare workers set for hydroxychloroquine trial to test if it can prevent COVID-19.

Natasha Robinson

The Times

ESCAPE: CRUISE COVER OPTION .. View of a Princess cruise ship docked at Whittier with hiker on Portage Pass, Chugach National Forest, Alaska. Picture: Getty

Alaskan slope sparks tsunami fear

A chance sighting from a tourist boat has led researchers to warn a catastrophic tsunami could be triggered in Alaska within a year.

ben hoyle

testingWorld

In this screen grab from video issued by Britain's Oxford University, a volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine, led by Oxford University in England on April 25, 2020. About 100 research groups around the world are pursuing vaccines against the coronavirus, with nearly a dozen in early stages of human trials or poised to start. (University of Oxford via AP)

Oxford vaccine fails animal trials

An analysis of the Oxford University coronavirus trials has revealed that the test vaccine failed to stop coronavirus in animals.

Jacquelin Magnay

COVID-19The Wall Street Journal

A lab worker inside a Norwood, Mass., facility of Moderna Inc., one of the drugmakers already testing a Covid-19 vaccine in humans. PHOTO: ADAM GLANZMAN FOR THE WALL STREET JOURNA

Vaccine frontrunners emerge amid rollout debate

Drugmakers build capacity to make hundreds of millions of doses, while governments discuss: who will get it first?

Peter Loftus

cyberspiesThe Wall Street Journal

China, Iran hack vaccine research

Chinese hackers are targeting US researchers in a bid to steal intellectual property related to coronavirus vaccines.

GORDON LUBOLD and DUSTIN VOLZ

After COVID-19The Times

In this Monday, May 11, 2020 photo, staff applaud as a nurse, wearing a face mask and a shield to protect against coronavirus, carries baby Amine Tepe who was infected with COVID-19, as she is taken out of the intensive care unit following a week's treatment, at an Istanbul hospital. Tepe was diagnosed with coronavirus when she was 37 days old after contracting the virus from her parents according to doctors. The baby has been moved to a hospital ward. Turkey's government announced a "normalization plan" as the number of new virus cases declined last week but warned of tougher measures, if infections go up again. (Ibrahim Mase/DHA via AP)

How to prepare for the next pandemic

As the world reels from the worst pandemic in a century, scientists are calling for new warning systems, tools to track the emergence of exotic pathogens and a battery of anti-viral drugs.

Rhys Blakely

CoronavirusNation

This 2020 electron microscope made available by the U.S. Centers for Disease Control and Prevention image shows the spherical coronavirus particles from the first U.S. case of COVID-19. On Monday, May 4, 2020, New York City health authorities issued an alert to doctors about severe inflammatory condition possibly linked with COVID-19 has been found in a cluster of U.S. children in New York City after first being reported in Europe. On Wednesday, New York said 64 potential cases had been reported to the state. Fever, abdominal pain and skin rashes are common symptoms of the unnamed condition, which has features similar to Kawasaki disease and toxic shock syndrome. (C.S. Goldsmith, A. Tamin/CDC via AP)

Probe into mystery disease in kids

The nation’s chief health officer will brief national cabinet on the deadly inflammatory disease apparently linked to COVID-19.

Natasha Robinson

Science

Drought ravaged fields west of Cunnamulla in Queensland. Photo Lachie Millard

Worst droughts are yet to come

More severe than the worst recorded by modern instruments are likely in the future, a new study has found.

Graham Lloyd

PANDEMIC ORIGINSScience

CORRECTION - Molecular biologist William Dundon runs a test to detect whether a person has been infected with COVID-19, at the IAEA's Laboratories in Seibersdorf, Austria, on May 7, 2020. - Shortages of materials needed in tests for the novel coronavirus continue to be "critical", according to the head of a UN lab, which is supplying countries with COVID-19 detection tests. (Photo by JOE KLAMAR / AFP) / “The erroneous mention[s] appearing in the metadata of this photo by JOE KLAMAR has been modified in AFP systems in the following manner: [Molecular biologist William Dundon] instead of [Giovanni Cattoli, head of the joint FAO/IAEA Animal Production and Health Laboratory]. Please immediately remove the erroneous mention[s] from all your online services and delete it (them) from your servers. If you have been authorized by AFP to distribute it (them) to third parties, please ensure that the same actions are carried out by them. Failure to promptly comply with these instructions will entail liability on your part for any continued or post notification usage. Therefore we thank you very much for all your attention and prompt action. We are sorry for the inconvenience this notification may cause and remain at your disposal for any further information you may require.”

People infected ‘weeks earlier than thought’

New research makes the case coronavirus began circulating around the world well before the first reported Chinese cases in January and February.

Jacquelin Magnay

MagazineWeekend Australian Magazine

TOPSHOT - This photo taken on April 15, 2020 shows vendors wearing face masks as they offer prawns for sale at the Wuhan Baishazhou Market in Wuhan in China's central Hubei province. - China's "wet" markets have gained a bad international reputation as the coronavirus roiling the world is believed to have been born in stalls selling live game in Wuhan late last year. (Photo by Hector RETAMAL / AFP) / TO GO WITH Health-virus-China,SCENE by Jing Xuan Teng

WHO’s stunning failure as coronavirus lay in wait

Early in 2018 a meeting of experts at WHO headquarters discussed the looming threat of ‘Disease X’. So how were we left so flat-footed by Covid-19?

Jennifer Kahn

exclusiveScience

This image obtained March 12, 2020 courtesy of The National Institutes of Health(NIH)/NIAD-RML shows a scanning electron microscope image of SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab, SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19, the virus shown was isolated from a patient in the US. - US President Donald Trump announced a shock 30-day ban on travel from mainland Europe over the coronavirus pandemic that has sparked unprecedented lockdowns, widespread panic and another financial market meltdown March 12, 2020. Trump's unexpected move in a primetime TV address from the Oval Office pummelled stock markets, as traders fretted about the economic impact of the outbreak that is on a seemingly relentless march across the planet. (Photo by Handout / National Institutes of Health / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /NATIONAL INSTITUTES OF HEALTH/NIAD-RML/HANDOUT " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

Mutant strain of virus spreading

About half the COVID-19 cases in Australia studied by the CSIRO have been found to be a mutant strain that may be more contagious.

Natasha Robinson

commentTechnology

AustraliaÕs Chief Scientist, Dr Alan Finkel, listening to Dr Larry Marshall, Chief Executive of CSIRO speak at The National Press Club in Canberra. Picture Kym Smith

AI on my device, not in the cloud

Nearly everything you do on your smartphone is stored, deconstructed and analysed by servers devoid of any morals.

Dr Alan Finkel

drugNation

Career One-bcm 29/10/07 Garry Redlich of Implicit Bioscience. They have been awarded an $18 million US Department of Defence grant to develop a bio-defence drug. Pic Mark Calleja

Trial treatment targets worst cases

An anti-inflammatory drug is set to be tested in clinical trials as a way to prevent the most deadly phase of COVID-19.

Natasha Robinson

treatmentNation

FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas.At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat COVID-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. (AP Photo/John Locher,File)

Trial of disputed drug to go ahead

Researchers leading a major clinical trial into hydroxychloroquine have addressed concerns over whether they should administer the drug.

Natasha Robinson

researchScience

Generic pic of a scientist using a microscope. Picture: Supplied

MS drug may reduce infections

Australian researchers will test whether a drug used to treat multiple sclerosis makes people with coronavirus less infectious.

Paige Taylor

Science

ERLANGEN, GERMANY - APRIL 27: A recovered Covid-19 patient donates blood plasma for research into Covid-19 antibodies at the medical researcher of the German Center for Immunity Therapy (das Deutsche Zentrum Immuntherapie, or DZI) at the University Hospital Erlangen during the novel coronavirus crisis on April 27, 2020 in Erlangen, Germany. The DZI is among several research facilities across Germany conducting research and tests over whether blood plasma that contains the antibodies from recovered Covid-19 patients might provide a therapy for other Covid-19 patients still battling with the disease. Germany currently has over 150,000 confirmed cases of Covid-19 infection, 103,000 people have recovered and approximately 6,000 people have died. (Photo by Alexander Hassenstein/Getty Images)

Recovered patients key to trials

Plasma extracted from those who have recovered from COVID-19 will be injected into those with active infections as part of a new treatment.

Natasha Robinson

The Times

In this photo released by Xinhua News Agency, China's new large carrier rocket Long March-5B blasts off from the Wenchang Space Launch Center in southern China's Hainan Province, May 5, 2020. The Long March-5B made its maiden flight on Tuesday, sending the trial version of China's new-generation manned spaceship and a cargo return capsule for test into space. (Tu Haichao/Xinhua via AP)

Beijing lunar race lifts off

China has announced a big advance in its space program, with the launch of its most advanced rocket.

didi tang

Five Eyes probeWorld

***Embargoed for The Daily Telegraph.*** Peng Zhou, Number two in the 'bat unit' at the Wuhan Institute of VirologySpent three years at the Australian Animal Health Laboratory and Biosecurity Business Unit from July 2011 until July 2014.http://sourcedb.whiov.cas.cn/zw/rck/201705/t20170505_4783973.html

Minister ‘unaware’ of Wuhan scientists investigation

Simon Bimingham denies knowledge of intelligence agencies investigating Chinese scientists who studied bats in Australia.

Angelica Snowden

Original URL: https://www.theaustralian.com.au/science/page/92